![News](https://firebrickpharmabucket.s3.ap-southeast-2.amazonaws.com/wp-content/uploads/2021/11/23084701/hero-banner.jpg)
Posts Tagged ‘announcement’
Nasodine research points to potential role in CRS
We are pleased to announce the publication of new research into Nasodine ® Nasal Spray (“Nasodine”) identifying its potential in the management of chronic rhinosinusitis (CRS). Sponsored by Firebrick, the research was conducted at the University of Auckland and has now been published in the prestigious journal, The Laryngoscope1. “To date, the development of Nasodine…
Firebrick announces formation of Scientific Advisory Board
Firebrick appoints four inaugural members to SAB Esteemed international panel with a wealth of medical and scientific experience SAB chaired by one of Australia’s leading virologists, Dr Simon Tucker We are pleased to announce the formation of a Scientific Advisory Board (SAB) to guide the Company’s research and development initiatives, including current new product development…